BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34496826)

  • 1. Leflunomide therapy for IgA vasculitis with nephritis in children.
    Hou L; Zhang Z; Du Y
    BMC Pediatr; 2021 Sep; 21(1):391. PubMed ID: 34496826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
    Delbet JD; Hogan J; Aoun B; Stoica I; Salomon R; Decramer S; Brocheriou I; Deschênes G; Ulinski T
    Pediatr Nephrol; 2017 Jul; 32(7):1193-1199. PubMed ID: 28204946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for preventing and treating kidney disease in IgA vasculitis.
    Hahn D; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD005128. PubMed ID: 36853224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
    Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
    Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?
    Jelusic M; Sestan M; Cimaz R; Ozen S
    Pediatr Rheumatol Online J; 2019 Feb; 17(1):10. PubMed ID: 30819179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
    J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Sipjeondaebo-tang (JAROTANG) for Henoch-Schonlein purpura nephritis (HSPN): Two case reports.
    Cho S; Jang S; Ryu SS; Park S
    Explore (NY); 2023; 19(3):439-444. PubMed ID: 36280432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb.
    Xia Y; Mao J; Chen Y; Wang D; Cao L; Yao S; Fu H; Du L; Liu A
    Pediatr Nephrol; 2011 Jul; 26(7):1083-8. PubMed ID: 21387156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsy-proven Henoch-Schönlein purpura nephritis: a single center experience.
    Kurt-Şükür ED; Sekar T; Tullus K
    Pediatr Nephrol; 2021 May; 36(5):1207-1215. PubMed ID: 33089378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early clinical course of biopsy-proven IgA vasculitis nephritis.
    Butzer S; Hennies I; Gimpel C; Gellermann J; Schalk G; König S; Büscher AK; Lemke A; Pohl M
    BMC Pediatr; 2022 Oct; 22(1):570. PubMed ID: 36195856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of renin-angiotensin system inhibitors as initial therapy in children with Henoch-Schönlein purpura nephritis of moderate severity.
    Nagai S; Horinouchi T; Ninchoji T; Kondo A; Aoto Y; Ishiko S; Sakakibara N; Nagano C; Yamamura T; Kaito H; Tanaka R; Shima Y; Fujimura J; Kamiyoshi N; Ishimori S; Nakanishi K; Yoshikawa N; Iijima K; Nozu K
    Pediatr Nephrol; 2022 Aug; 37(8):1845-1853. PubMed ID: 35015121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.
    Yu M; Song X; Guo J; Feng Q; Tian J
    Eur J Pediatr; 2024 Jul; 183(7):3117-3128. PubMed ID: 38668796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-center analysis of Henoch-Schonlein purpura nephritis with nephrotic proteinuria in children.
    Feng D; Huang WY; Hao S; Niu XL; Wang P; Wu Y; Zhu GH
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):15. PubMed ID: 28257644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA vasculitis (Henoch-Schönlein purpura) nephritis and psoriasis in a child: is there a relationship?
    Vaz AS; Penteado R; Cordinhã C; Carmo C; Gomes C
    J Bras Nefrol; 2021; 43(4):603-607. PubMed ID: 33605313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful therapy with tonsillectomy for severe ISKDC grade VI Henoch-Schönlein purpura nephritis and persistent nephrotic syndrome.
    Ohara S; Kawasaki Y; Matsuura H; Oikawa T; Suyama K; Hosoya M
    Clin Exp Nephrol; 2011 Oct; 15(5):749-753. PubMed ID: 21618075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and outcomes of diffuse endocapillary proliferation Henoch-Schönlein purpura nephritis in children.
    Fu H; Mao J; Xu Y; Gu W; Zhu X; Liu A
    Clinics (Sao Paulo); 2016 Sep; 71(9):550-4. PubMed ID: 27652838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half of children with IgA vasculitis-associated nephritis with nephrotic state spontaneously recover.
    Deki S; Hamada R; Mikami N; Terano C; Harada R; Hamasaki Y; Ishikura K; Honda M; Hataya H
    Nephrology (Carlton); 2022 Aug; 27(8):681-689. PubMed ID: 35362228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid- and immunosuppressant-based protocol of Henoch-Schönlein purpura nephritis without angiotensin inhibitors in the acute phase.
    Kasahara K; Gotoh Y; Kuroyanagi Y; Nagano C; Yamakawa S; Tanaka K; Takeda A; Uemura O
    Minerva Pediatr (Torino); 2023 Apr; 75(2):201-209. PubMed ID: 30419744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study.
    Song YR; Guo WL; Sheng M; Lin Q; Zhu XM; Li XZ
    BMC Pediatr; 2020 Nov; 20(1):501. PubMed ID: 33131493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.
    Buscatti IM; Casella BB; Aikawa NE; Watanabe A; Farhat SCL; Campos LMA; Silva CA
    Clin Rheumatol; 2018 May; 37(5):1319-1324. PubMed ID: 29330742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.